Product information
From Health Canada
Current status:
Cancelled Post Market
Current status date:
2009-02-23
Original market date: See footnote 1
1997-12-15
Product name:
EMINASE 30 UNITS
DIN:
02229390 Electronic product monograph is not available
Company:
WELLSPRING PHARMACEUTICAL CANADA CORP
600
1741 Lower Water St
Halifax
Nova Scotia
Canada
B3J 0J2
Class:
Human
Dosage form(s):
Powder For Solution
Route(s) of administration:
Intravenous
Number of active ingredient(s):
1
Schedule(s):
Schedule D
American Hospital Formulary Service (AHFS): See footnote 3
20:12.20
Anatomical Therapeutic Chemical (ATC): See footnote 4
B01AD03 ANISTREPLASE
Active ingredient group (AIG) number:See footnote5
0122566002
Active ingredient(s) See footnote8 | Strength |
---|---|
ANISTREPLASE | 30 UNIT / 5 ML |